Friday 6 November 2026
Export STAA’s income statement to Excel — free account
STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
STAAR Surgical Company’s revenue for fiscal 2025 (year ended December 2025) was $239.4 million, down 23.7% from fiscal 2024.
- Revenue
- −12.0%
- EPS
- −38.9%
- Free cash flow
- +1,378.7%
Quarter to September 2026, against a year earlier
25.51
1.21
−4.53%
Follow STAA
Alert me
STAAR Surgical Company (STAA) P/E ratio
STAAR Surgical Company has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,540× (June 2018) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 66.1× | 3.13% |
| FY2022 | 64.1× | (58.81%) |
| FY2021 | 156× | (77.03%) |
| FY2020 | 677× | 496.81% |
| FY2019 | 113× | (62.99%) |
| FY2018 | 307× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 410× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,540×
Ten-year median
83.2×
Current reading's percentile
41
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| STAA STAAR Surgical Company | n/m |
| ANGO AngioDynamics, Inc. compare | n/m |
| AZTA Azenta, Inc. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| LMAT LeMaitre Vascular, Inc. compare | 29.7× |
| ATRC AtriCure, Inc. compare | 199× |
| WRBY Warby Parker Inc. compare | 434× |
| NNNN Anbio Biotechnology compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)